Shanghai Industrial Urban Development Group Limited (Stock Code: 563) disclosed that on 13 November 2025, its indirect wholly-owned subsidiary SIUD Shanghai Healthcare Management, together with Shanghai Huashi, conditionally agreed to sell an aggregate 49% equity interest in Shanghai Shangshi Medical Cosmetology Hospital Co., Ltd. (the Target Company) to Shanghai Lingfeng Medical for RMB73,598,000. Shanghai Lingfeng Medical is a wholly-owned subsidiary of SIIC, the controlling shareholder of SIUD (563).

Upon completion of the transaction, SIUD (563) will cease to hold any stake in the Target Company, which will become wholly owned by Shanghai Lingfeng Medical. The Group’s 19% portion, previously accounted for as an associate, will be disposed of for RMB28,538,000. A gain of approximately RMB8,430,000 is expected, subject to final audit.

An independent valuation report supported the disposal price, applying an income approach with an 11.0% discount rate and a 0% perpetual growth rate after 2031. The disposal was undertaken to streamline the Group’s investment portfolio and concentrate resources on core operations. As the total applicable percentage ratios exceed 0.1% but remain below 5%, the transaction is subject to reporting and announcement requirements and is exempt from shareholders’ circular and approval requirements under Chapter 14A of the Listing Rules.